226
Views
8
CrossRef citations to date
0
Altmetric
Research Article

The distribution of HLA-B27 subtype in patients with ankylosing spondylitis in Northern Norway

, &
Pages 296-300 | Accepted 05 Nov 2013, Published online: 11 Feb 2014

References

  • Sieper J, Rudwaleit M, Khan MA, Braun J. Concepts and epidemiology of spondyloarthritis. Best Pract Res Clin Rheumatol 2006;20:401–17.
  • Khan MA, Ball EJ. Genetic aspects of ankylosing spondylitis. Best Pract Res Clin Rheumatol 2002;16:675–90.
  • Mathieu A, Cauli A, Fiorillo MT, Sorrentino R. HLA-B27 and ankylosing spondylitis geographic distribution versus malaria endemic: casual or causal liaison? Ann Rheum Dis 2008; 67:138–40.
  • Brown MA, Jepson A, Young A, Whittle HC, Greenwood BM, Wordsworth BP. Ankylosing spondylitis in West Africans – evidence for a non-HLA-B27 protective effect. Ann Rheum Dis 1997;56:68–70.
  • Adebajo A, Davis P. Rheumatic diseases in African blacks. Semin Arthritis Rheum 1994;24:139–53.
  • Mijiyawa M, Oniankitan O, Khan MA. Spondyloarthropathies in sub-Saharan Africa. Curr Opin Rheumatol 2000;12:281–6.
  • Gofton JP, Chalmers A, Price GE, Reeve CE. HL-A27 and ankylosing spondylitis in B.C. Indians. J Rheumatol 1984;11:572–3.
  • Thorsby E. HL-A antigens and genes. I. A study of unrelated Norwegians. Vox Sang 1969;17:81–92.
  • Brewerton DA, Hart FD, Nicholls A, Caffrey M, James DC, Sturrock RD. Ankylosing spondylitis and HL-A 27. Lancet 1973;1:904–7.
  • Schlosstein L, Terasaki PI, Bluestone R, Pearson CM. High association of an HL-A antigen, W27, with ankylosing spondylitis. N Engl J Med 1973;288:704–6.
  • Gran JT, Husby G. Clinical, epidemiologic, and therapeutic aspects of ankylosing spondylitis. Curr Opin Rheumatol 1998;10:292–8.
  • Brown MA. Breakthroughs in genetic studies of ankylosing spondylitis. Rheumatology (Oxford) 2008;47:132–7.
  • Gran JT, MellbyAS, Husby G. The prevalence of HLA-B27 in Northern Norway. Scand J Rheumatol 1984;13:173–6.
  • Johnsen K, Gran JT, Dale K, Husby G. The prevalence of ankylosing spondylitis among Norwegian Samis (Lapps). J Rheumatol 1992; 19:1591–4.
  • Bakland G, Nossent HC, Gran JT. Incidence and prevalence of ankylosing spondylitis in Northern Norway. Arthritis Rheum 2005;53:850–5.
  • Madden DR, Gorga JC, Strominger JL, Wiley DC. The structure of HLA-B27 reveals nonamer self-peptides bound in an extended conformation. Nature 1991;353:321–5.
  • Khan MA. Polymorphism of HLA-B27: 105 subtypes currently known. Curr Rheumatol Rep 2013;15:362.
  • Weiss EH, Bloemer K, Doerner C, Kuon W, Lang M, Pohla H, Molecular biology of the HLA-B27 locus. Br J Rheumatol 1988;27(Suppl 2):12–18.
  • Khan MA. Update: the twenty subtypes of HLA-B27. Curr Opin Rheumatol 2000;12:235–8.
  • Gonzalez S, Garcia-Fernandez S, Martinez-Borra J, Blanco-Gelaz MA, Rodrigo L, Sanchez del Rio J, High variability of HLA-B27 alleles in ankylosing spondylitis and related spondyloarthropathies in the population of northern Spain. Hum Immunol 2002;63:673–6.
  • Reveille JD. Major histocompatibility genes and ankylosing spondylitis. Best Pract Res Clin Rheumatol 2006;20:601–9.
  • Reveille JD. The genetic basis of ankylosing spondylitis. Curr Opin Rheumatol 2006;18:332–41.
  • Mathieu A, Cauli A, Fiorillo MT, Sorrentino R. HLA-B27 and ankylosing spondylitis geographic distribution as the result of a genetic selection induced by malaria endemic? A review supporting the hypothesis. Autoimmun Rev 2008;7:398–403.
  • Khan MA, Mathieu A, Sorrentino R, Akkoc N. The pathogenetic role of HLA-B27 and its subtypes. Autoimmun Rev 2007;6:183–9.
  • Baech J, Schmidt-Olsen S, Steffensen R, Varming K, Grunnet N, Jersild C. Frequency of HLA-B27 subtypes in a Danish population and in Danish patients with ankylosing spondylitis. Tissue Antigens 1997;49:499–502.
  • Bakland G, Gran JT, Nossent JC. Increased mortality in ankylosing spondylitis is related to disease activity. Ann Rheum Dis 2011; 70:1921–5.
  • Fruci D, Greco G, Vigneti E, Tanigaki N, Butler RH, Tosi R. The peptide-binding specificity of HLA-B27 subtype (B*2705) analyzed by the use of polyalanine model peptides. Hum Immunol 1994;41:34–8.
  • Uchanska-Ziegler B, Loll B, Fabian H, Hee CS, Saenger W, Ziegler A. HLA class I-associated diseases with a suspected autoimmune etiology: HLA-B27 subtypes as a model system. Eur J Cell Biol 2012;91:274–86.
  • Winkler K, Winter A, Rueckert C, Uchanska-Ziegler B, Alexiev U. Natural MHC class I polymorphism controls the pathway of peptide dissociation from HLA-B27 complexes. Biophys J 2007;93:2743–55.
  • Schellens IM, Keşmir C, Miedema F, van Baarle D, Borghans JA. An unanticipated lack of consensus cytotoxic T lymphocyte epitopes in HIV-1 databases: the contribution of prediction programs. AIDS 2008;22:33–7.
  • Cornelissen M, Hoogland FM, Back NK, Jurriaans S, Zorgdrager F, Bakker M, Multiple transmissions of a stable human leucocyte antigen-B27 cytotoxic T-cell-escape strain of HIV-1 in The Netherlands. AIDS 2009;23:1495–500.
  • Nurzia E, Narzi D, Cauli A, Mathieu A, Tedeschi V, Caristi S, Interaction pattern of Arg 62 in the A-pocket of differentially disease-associated HLA-B27 subtypes suggests distinct TCR binding modes. PLoS One 2012;7:e32865.
  • Lopez de Castro JA. HLA-B27: portraying immunodominant viral epitopes. Eur J Immunol 2005;35:336–40.
  • Ward MM, Hendrey MR, Malley JD, Learch TJ, Davis JC Jr, Reveille JD, Clinical and immunogenetic prognostic factors for radiographic severity in ankylosing spondylitis. Arthritis Rheum 2009;61:859–66.
  • Garcia-Fernandez S, Gonzalez S, Mina BA, Martinez-Borra J, Blanco-Gelaz M, Lopez-Vazquez A, New insights regarding HLA-B27 diversity in the Asian population. Tissue Antigens 2001;58:259–62.
  • Brown MA, Pile KD, Kennedy LG, Calin A, Darke C, Bell J, HLA class I associations of ankylosing spondylitis in the white population in the United Kingdom. Ann Rheum Dis 1996;55:268–70.
  • Fernandez-Sueiro JL, Alonso C, Blanco FJ, Rodriguez-Gomez M, Galdo F, Gonzalez-Gay MA. Prevalence of HLA-B27 and subtypes of HLA-B27 associated with ankylosing spondylitis in Galicia, Spain. Clin Exp Rheumatol 2004;22:465–8.
  • Cascino I, Paladini F, Belfiore F, Cauli A, Angelini C, Fiorillo MT, Identification of previously unrecognized predisposing factors for ankylosing spondylitis from analysis of HLA-B27 extended haplotypes in Sardinia. Arthritis Rheum 2007;56:2640–51.
  • Varnavidou-Nicolaidou A, Karpasitou K, Georgiou D, Stylianou G, Kokkofitou A, Michalis C, HLA-B27 in the Greek Cypriot population: distribution of subtypes in patients with ankylosing spondylitis and other HLA-B27-related diseases. The possible protective role of B*2707. Hum Immunol 2004;65:1451–4.
  • Lopez-Larrea C, Gonzalez-Roces S, Pena M, Dominguez O, Coto E, Alvarez V, Characterization of B27 haplotypes by oligotyping and genomic sequencing in the Mexican Mestizo population with ankylosing spondylitis: juvenile and adult onset. Hum Immunol 1995;43:174–80.
  • Olerup O. HLA-B27 typing by a group-specific PCR amplification. Tissue Antigens 1994;43:253–6.
  • Frankenberger B, Breitkopf S, Albert E, Scholz S, Keller E, Schattenkirchner M, Routine molecular genotyping of HLA-B27 in spondyloarthropathies overcomes the obstacles of serological typing and reveals an increased B *2702 frequency in ankylosing spondylitis. J Rheumatol 1997;24: 899–903.
  • Kirveskari J, Kellner H, Wuorela M, Soini H, Frankenberger B, Leirisalo-Repo M, False-negative serological HLA-B27 typing results may be due to altered antigenic epitopes and can be detected by polymerase chain reaction. Br J Rheumatol 1997;36:185–9.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.